207 related articles for article (PubMed ID: 11081146)
21. Chronic central infusion of growth hormone secretagogues: effects on fos expression and peptide gene expression in the rat arcuate nucleus.
Bailey AR; Giles M; Brown CH; Bull PM; Macdonald LP; Smith LC; Smith RG; Leng G; Dickson SL
Neuroendocrinology; 1999 Aug; 70(2):83-92. PubMed ID: 10461022
[TBL] [Abstract][Full Text] [Related]
22. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
23. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
Riedel M; Günther T; von zur Mühlen A; Brabant G
Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
[TBL] [Abstract][Full Text] [Related]
24. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
25. Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.
Kovacs M; Kineman RD; Schally AV; Flerko B; Frohman LA
J Neuroendocrinol; 2000 Apr; 12(4):335-41. PubMed ID: 10718930
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
Giustina A; Desenzani P; Perini P; Deghenghi R; Bugari G; Wehrenberg WB; Giustina G
Endocr Res; 1996 May; 22(2):159-74. PubMed ID: 8799695
[TBL] [Abstract][Full Text] [Related]
27. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
28. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic galanin administration decreases hypothalamic galanin synthesis in both male and female adult rats: evidence for a long-loop galanin autofeedback.
Giustina A; Brogan R; Conley L; Godi D; Manelli F; Wehrenberg WB
Metabolism; 2000 Jun; 49(6):778-83. PubMed ID: 10877206
[TBL] [Abstract][Full Text] [Related]
30. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
31. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB
Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
[TBL] [Abstract][Full Text] [Related]
32. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.
Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB
Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat.
Soszynski PA; Frohman LA
Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962
[TBL] [Abstract][Full Text] [Related]
34. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
35. Modulation of growth hormone-releasing activity of hexarelin in man.
Arvat E; Gianotti L; Di Vito L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1995 Jan; 61(1):51-6. PubMed ID: 7731498
[TBL] [Abstract][Full Text] [Related]
36. Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women.
Giustina A; Gastaldi C; Bugari G; Chiesa L; Loda G; Tironi C; Negro-Vilar A
Metabolism; 1995 Aug; 44(8):1028-32. PubMed ID: 7543651
[TBL] [Abstract][Full Text] [Related]
37. Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.
Giustina A; Schettino M; Bodini C; Doga M; Licini M; Giustina G
Metabolism; 1992 Dec; 41(12):1291-4. PubMed ID: 1281259
[TBL] [Abstract][Full Text] [Related]
38. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.
Lee J; Kwon A; Chae HW; Lee WJ; Kim TH; Kim HS
Yonsei Med J; 2018 Dec; 59(10):1174-1180. PubMed ID: 30450851
[TBL] [Abstract][Full Text] [Related]
39. Induction of growth hormone (GH) mRNA by pulsatile GH-releasing hormone in rats is pattern specific.
Borski RJ; Tsai W; Demott-Friberg R; Barkan AL
Am J Physiol Endocrinol Metab; 2000 May; 278(5):E885-91. PubMed ID: 10780945
[TBL] [Abstract][Full Text] [Related]
40. Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism.
Giustina A; Bussi AR; Legati F; Bossoni S; Licini M; Schettino M; Zuccato F; Wehrenberg WB
Acta Endocrinol (Copenh); 1992 Dec; 127(6):504-8. PubMed ID: 1283476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
